Human Microbiome Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the human microbiome market looks promising with opportunities in the therapeutic industry. The global human microbiome market is expected to grow with a CAGR of 22%-24% from 2020 to 2025. The major drivers for this market are rise in advanced technology, increase in the aging population, rise in incidences of chronic diseases, and regulations by governmental bodies on probiotics and prebiotics.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global human microbiome market report, please download the report brochure.
In this market, genomics is the largest research technology of human microbiome, whereas infectious is the largest disease. Growth in various segments of the human microbiome market are given below:
The study includes trends and forecast for the global human microbiome market by product, disease, research technology, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
PrebioticProbioticFoodMedical FoodDrug
By Disease [Value ($ Million) shipment analysis for 2014 – 2025]:
InfectiousMetabolic/EndocrineCancerBloodNeurological
By Research Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
ProteomicsMetabolomicsGenomics
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanIndonesiaThe Rest of the WorldBrazil
Some of the human microbiome companies profiled in this report include Enterome Bioscience, Seres Therapeutics, 4D Pharma, Rebiotix, Yakult Honsha, Osel, Vedanta Biosciences, Synthetic Biologics, DuPont, and BiomX.
Lucintel forecasts that genomics will remain the largest research technology segment over the forecast period due to increasing number of projects funded by private and government bodies.
Within this market, therapeutic will remain the largest application segment over the forecast period due to the increase in funding for R&D into microbiome-based therapies.
North America is expected to witness the highest growth over the forecast period due to increasing incidences of lifestyle diseases, rising awareness of preventive healthcare, availability of funding for microbiome research, and growing acceptance of probiotic products.
Features of the Global Human Microbiome Market
Market Size Estimates: Global human microbiome market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global human microbiome market size by various segments, such as product, disease, and research technology in terms of value.Regional Analysis: Global human microbiome market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, disease, research technology, and region for the global human microbiome market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global human microbiome market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global human microbiome by product (prebiotic, probiotic, food, medical food, and drug), disease (infectious, metabolic/endocrine, cancer, blood, and neurological), research technology (proteomics, metabolomics, and genomics), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global human microbiome market?
Q.5 What are the business risks and threats to the global human microbiome market?
Q.6 What are emerging trends in this human microbiome market and the reasons behind them?
Q.7 What are some changing demands of customers in this human microbiome market?
Q.8 What are the new developments in this human microbiome market? Which companies are leading these developments?
Q.9 Who are the major players in this human microbiome market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this human microbiome market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global human microbiome market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Prebiotic, Probiotic, Food, Medical Food, and Drug), Disease (Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological), and Research Technology (Proteomics, Metabolomics, and Genomics)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the human microbiome market looks promising with opportunities in the therapeutic industry. The global human microbiome market is expected to grow with a CAGR of 22%-24% from 2020 to 2025. The major drivers for this market are rise in advanced technology, increase in the aging population, rise in incidences of chronic diseases, and regulations by governmental bodies on probiotics and prebiotics.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global human microbiome market report, please download the report brochure.
In this market, genomics is the largest research technology of human microbiome, whereas infectious is the largest disease. Growth in various segments of the human microbiome market are given below:
The study includes trends and forecast for the global human microbiome market by product, disease, research technology, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
PrebioticProbioticFoodMedical FoodDrug
By Disease [Value ($ Million) shipment analysis for 2014 – 2025]:
InfectiousMetabolic/EndocrineCancerBloodNeurological
By Research Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
ProteomicsMetabolomicsGenomics
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanIndonesiaThe Rest of the WorldBrazil
Some of the human microbiome companies profiled in this report include Enterome Bioscience, Seres Therapeutics, 4D Pharma, Rebiotix, Yakult Honsha, Osel, Vedanta Biosciences, Synthetic Biologics, DuPont, and BiomX.
Lucintel forecasts that genomics will remain the largest research technology segment over the forecast period due to increasing number of projects funded by private and government bodies.
Within this market, therapeutic will remain the largest application segment over the forecast period due to the increase in funding for R&D into microbiome-based therapies.
North America is expected to witness the highest growth over the forecast period due to increasing incidences of lifestyle diseases, rising awareness of preventive healthcare, availability of funding for microbiome research, and growing acceptance of probiotic products.
Features of the Global Human Microbiome Market
Market Size Estimates: Global human microbiome market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global human microbiome market size by various segments, such as product, disease, and research technology in terms of value.Regional Analysis: Global human microbiome market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, disease, research technology, and region for the global human microbiome market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global human microbiome market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global human microbiome by product (prebiotic, probiotic, food, medical food, and drug), disease (infectious, metabolic/endocrine, cancer, blood, and neurological), research technology (proteomics, metabolomics, and genomics), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global human microbiome market?
Q.5 What are the business risks and threats to the global human microbiome market?
Q.6 What are emerging trends in this human microbiome market and the reasons behind them?
Q.7 What are some changing demands of customers in this human microbiome market?
Q.8 What are the new developments in this human microbiome market? Which companies are leading these developments?
Q.9 Who are the major players in this human microbiome market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this human microbiome market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global human microbiome market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Prebiotic, Probiotic, Food, Medical Food, and Drug), Disease (Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological), and Research Technology (Proteomics, Metabolomics, and Genomics)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Human Microbiome Market Trends and Forecast
3.3: Global Human Microbiome Market by Product
3.3.1: Prebiotic
3.3.2: Probiotic
3.3.3: Food
3.3.4: Medical Food
3.3.5: Drug
3.4: Global Human Microbiome Market by Disease
3.4.1: Infectious
3.4.2: Metabolic/Endocrine
3.4.3: Cance
3.4.4: Blood
3.4.5: Neurological
3.5: Global Human Microbiome Market by Research Technology
3.5.1: Proteomics
3.5.2: Metabolomics
3.5.3: Genomics
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Human Microbiome Market by Region
4.2: North American Human Microbiome Market
4.2.1: Market by Product: Prebiotic, Probiotic, Food, Medical Food, and Drug
4.2.2: Market by Disease: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
4.2.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
4.2.4: The United States Human Microbiome Market
4.2.5: The Canadian Human Microbiome Market
4.2.6: The Mexican Human Microbiome Market
4.3: European Human Microbiome Market
4.3.1: Market by Product: Prebiotic, Probiotic, Food, Medical Food, and Drug
4.3.2: Market by Disease: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
4.3.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
4.3.4: The United Kingdom Human Microbiome Market
4.3.5: The Spanish Human Microbiome Market
4.3.6: The German Human Microbiome Market
4.3.7: The French Human Microbiome Market
4.4: APAC Human Microbiome Market
4.4.1: Market by Product: Prebiotic, Probiotic, Food, Medical Food, and Drug
4.4.2: Market by Disease: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
4.4.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
4.4.4: The Chinese Human Microbiome Market
4.4.5: The Indian Human Microbiome Market
4.4.6: The Japanese Human Microbiome Market
4.5: ROW Human Microbiome Market
4.5.1: Market by Product: Prebiotic, Probiotic, Food, Medical Food, and Drug
4.5.2: Market by Disease: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
4.5.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
4.5.4: Brazilian Human Microbiome Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Human Microbiome Market by Product
7.1.2: Growth Opportunities for the Global Human Microbiome Market by Disease
7.1.3: Growth Opportunities for the Global Human Microbiome Market by Application
7.1.4: Growth Opportunities for the Global Human Microbiome Market by Research Technology
7.1.5: Growth Opportunities for the Global Human Microbiome Market by Region
7.2: Emerging Trends in the Global Human Microbiome Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Human Microbiome Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Human Microbiome Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Enterome Bioscience
8.2: Seres Therapeutics
8.3: 4D Pharma
8.4: Rebiotix
8.5: Yakult Honsha
8.6: Osel
8.7: Vedanta Biosciences
8.8: Synthetic Biologics
8.9: DuPont
8.10: BiomX
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Human Microbiome Market Trends and Forecast
3.3: Global Human Microbiome Market by Product
3.3.1: Prebiotic
3.3.2: Probiotic
3.3.3: Food
3.3.4: Medical Food
3.3.5: Drug
3.4: Global Human Microbiome Market by Disease
3.4.1: Infectious
3.4.2: Metabolic/Endocrine
3.4.3: Cance
3.4.4: Blood
3.4.5: Neurological
3.5: Global Human Microbiome Market by Research Technology
3.5.1: Proteomics
3.5.2: Metabolomics
3.5.3: Genomics
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Human Microbiome Market by Region
4.2: North American Human Microbiome Market
4.2.1: Market by Product: Prebiotic, Probiotic, Food, Medical Food, and Drug
4.2.2: Market by Disease: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
4.2.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
4.2.4: The United States Human Microbiome Market
4.2.5: The Canadian Human Microbiome Market
4.2.6: The Mexican Human Microbiome Market
4.3: European Human Microbiome Market
4.3.1: Market by Product: Prebiotic, Probiotic, Food, Medical Food, and Drug
4.3.2: Market by Disease: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
4.3.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
4.3.4: The United Kingdom Human Microbiome Market
4.3.5: The Spanish Human Microbiome Market
4.3.6: The German Human Microbiome Market
4.3.7: The French Human Microbiome Market
4.4: APAC Human Microbiome Market
4.4.1: Market by Product: Prebiotic, Probiotic, Food, Medical Food, and Drug
4.4.2: Market by Disease: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
4.4.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
4.4.4: The Chinese Human Microbiome Market
4.4.5: The Indian Human Microbiome Market
4.4.6: The Japanese Human Microbiome Market
4.5: ROW Human Microbiome Market
4.5.1: Market by Product: Prebiotic, Probiotic, Food, Medical Food, and Drug
4.5.2: Market by Disease: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
4.5.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
4.5.4: Brazilian Human Microbiome Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Human Microbiome Market by Product
7.1.2: Growth Opportunities for the Global Human Microbiome Market by Disease
7.1.3: Growth Opportunities for the Global Human Microbiome Market by Application
7.1.4: Growth Opportunities for the Global Human Microbiome Market by Research Technology
7.1.5: Growth Opportunities for the Global Human Microbiome Market by Region
7.2: Emerging Trends in the Global Human Microbiome Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Human Microbiome Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Human Microbiome Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Enterome Bioscience
8.2: Seres Therapeutics
8.3: 4D Pharma
8.4: Rebiotix
8.5: Yakult Honsha
8.6: Osel
8.7: Vedanta Biosciences
8.8: Synthetic Biologics
8.9: DuPont
8.10: BiomX
